{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:02:48Z","timestamp":1791198168911,"version":"4.1.0"},"reference-count":75,"publisher":"Impact Journals, LLC","issue":"29","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,7,19]]},"DOI":"10.18632\/oncotarget.10160","type":"journal-article","created":{"date-parts":[[2016,6,18]],"date-time":"2016-06-18T12:31:14Z","timestamp":1466253074000},"page":"45730-45744","source":"Crossref","is-referenced-by-count":53,"title":["STAT5 induces miR-21 expression in cutaneous T cell lymphoma"],"prefix":"10.18632","volume":"7","author":[{"given":"Lise M.","family":"Lindahl","sequence":"first","affiliation":[{"name":"Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Fredholm","sequence":"additional","affiliation":[{"name":"Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudine","family":"Joseph","sequence":"additional","affiliation":[{"name":"Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boye Schnack","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Bioneer A\/S, H\u00f8rsholm, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"J\u00f8nson","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Copenhagen University Hospital, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Willerslev-Olsen","sequence":"additional","affiliation":[{"name":"Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Gluud","sequence":"additional","affiliation":[{"name":"Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edda","family":"Bl\u00fcmel","sequence":"additional","affiliation":[{"name":"Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Petersen","sequence":"additional","affiliation":[{"name":"Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Sibbesen","sequence":"additional","affiliation":[{"name":"Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tengpeng","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Nastasi","sequence":"additional","affiliation":[{"name":"Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorbj\u00f8rn","family":"Krejsgaard","sequence":"additional","affiliation":[{"name":"Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ditte","family":"J\u00e6hger","sequence":"additional","affiliation":[{"name":"Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny L.","family":"Persson","sequence":"additional","affiliation":[{"name":"Clinical Research Center, Lund University, Malm\u00f6, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Mongan","sequence":"additional","affiliation":[{"name":"School of Veterinary Medicine and Science, University of Nottingham, Loughborough, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariusz A.","family":"Wasik","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan V.","family":"Litvinov","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Sasseville","sequence":"additional","affiliation":[{"name":"Division of Dermatology, McGill University Health Centre, Montr\u00e9al, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergei B.","family":"Koralov","sequence":"additional","affiliation":[{"name":"Department of Pathology, New York University School of Medicine, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte M.","family":"Bonefeld","sequence":"additional","affiliation":[{"name":"Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Geisler","sequence":"additional","affiliation":[{"name":"Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Woetmann","sequence":"additional","affiliation":[{"name":"Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Ralfkiaer","sequence":"additional","affiliation":[{"name":"Department of Pathology, Copenhagen University Hospital, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Iversen","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Odum","sequence":"additional","affiliation":[{"name":"Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,6,18]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1056\/NEJMra032810","article-title":"The pathogenesis of mycosis fungoides","volume":"350","author":"Wilson","year":"2004","journal-title":"N Engl J Med"},{"key":"2","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Kempf","year":"2005","journal-title":"Blood"},{"key":"3","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1200\/JCO.2009.27.7665","article-title":"Survival outcomes and prognostic factors in mycosis fungoides\/Sezary syndrome: validation of the revised International Society for Cutaneous Lymphomas\/European Organisation for Research and Treatment of Cancer staging proposal","volume":"28","author":"Dean","year":"2010","journal-title":"J Clin Oncol"},{"key":"4","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.4161\/cbt.12.12.18144","article-title":"The role of cytokine signaling in the pathogenesis of cutaneous T-cell lymphoma","volume":"12","author":"Wasik","year":"2011","journal-title":"Cancer Biol Ther"},{"key":"5","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.clml.2013.02.020","article-title":"Duration of response in cutaneous T-cell lymphoma patients treated with denileukin diftitox: results from 3 phase III studies","volume":"13","author":"Prince","year":"2013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"6","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1182\/blood.V92.1.252.413k08_252_258","article-title":"Interleukin-15 is an autocrine\/paracrine viability factor for cutaneous T-cell lymphoma cells","volume":"92","author":"Burg","year":"1998","journal-title":"Blood"},{"key":"7","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1182\/blood.V98.9.2778","article-title":"Interleukin-7 and interleukin-15 regulate the expression of the bcl-2 and c-myb genes in cutaneous T-cell lymphoma cells","volume":"98","author":"Dobbeling","year":"2001","journal-title":"Blood"},{"key":"8","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.4161\/cc.28256","article-title":"IL-15 and IL-17F are differentially regulated and expressed in mycosis fungoides (MF)","volume":"13","author":"Sasseville","year":"2014","journal-title":"Cell cycle"},{"key":"9","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1182\/blood-2005-03-1139","article-title":"Skin-derived interleukin-7 contributes to the proliferation of lymphocytes in cutaneous T-cell lymphoma","volume":"107","author":"Kupper","year":"2006","journal-title":"Blood"},{"key":"10","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/sj.leu.2403385","article-title":"activation of STAT3 in cutaneous T-cell lymphoma. Evidence for an antiapoptotic function of STAT3","volume":"18","author":"Odum","year":"2004","journal-title":"Leukemia"},{"key":"11","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1007\/s00262-007-0285-4","article-title":"Interleukin 21 therapy increases the density of tumor infiltrating CD8+ T cells and inhibits the growth of syngeneic tumors","volume":"56","author":"Kragh","year":"2007","journal-title":"Cancer Immunol Immunother"},{"key":"12","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/jid.2010.349","article-title":"MicroRNA-21 expression in CD4+ T cells is regulated by STAT3 and is pathologically involved in Sezary syndrome","volume":"131","author":"Vermeer","year":"2011","journal-title":"J Invest Dermatol"},{"key":"13","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1158\/0008-5472.CAN-07-6091","article-title":"Constitutive activation of signal transducers and activators of transcription predicts vorinostat resistance in cutaneous T-cell lymphoma","volume":"68","author":"Reilly","year":"2008","journal-title":"Cancer Res"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.6916","article-title":"Disruption of CCL20-CCR6 interaction inhibits metastasis of advanced cutaneous T-cell lymphoma","author":"Tagawa","year":"2016","journal-title":"Oncotarget"},{"key":"15","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1182\/blood-2013-01-480889","article-title":"Elucidating the role of interleukin-17F in cutaneous T-cell lymphoma","volume":"122","author":"Sasseville","year":"2013","journal-title":"Blood"},{"key":"16","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1038\/sj.leu.2404350","article-title":"Jak3- and JNK-dependent vascular endothelial growth factor expression in cutaneous T-cell lymphoma","volume":"20","author":"Odum","year":"2006","journal-title":"Leukemia"},{"key":"17","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1182\/blood-2014-01-551184","article-title":"Staphylococcal enterotoxins stimulate lymphoma-associated immune dysregulation","volume":"124","author":"Odum","year":"2014","journal-title":"Blood"},{"key":"18","doi-asserted-by":"publisher","first-page":"15235","DOI":"10.18632\/oncotarget.3837","article-title":"Malignant T cells express lymphotoxin alpha and drive endothelial activation in cutaneous T cell lymphoma","volume":"6","author":"Odum","year":"2015","journal-title":"Oncotarget"},{"key":"19","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1182\/blood.V99.3.973","article-title":"Spontaneous interleukin-5 production in cutaneous T-cell lymphoma lines is mediated by constitutively activated Stat3","volume":"99","author":"Odum","year":"2002","journal-title":"Blood"},{"key":"20","first-page":"1784","article-title":"STAT3\/5 dependent IL-9 overexpression contributes to neoplastic cell survival in mycosis fungoides","author":"Wolf","year":"2016","journal-title":"Clin Cancer Res"},{"key":"21","doi-asserted-by":"crossref","first-page":"5507","DOI":"10.1158\/1078-0432.CCR-14-0707","article-title":"Deficient cutaneous antibacterial competence in cutaneous T-cell lymphomas: role of Th2-mediated biased Th17 function","volume":"20","author":"Sterry","year":"2014","journal-title":"Clin Cancer Res"},{"key":"22","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jaad.2009.11.692","article-title":"Infectious agents in cutaneous T-cell lymphoma","volume":"64","author":"Geskin","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"23","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.clindermatol.2013.01.009","article-title":"Role of infectious agents in cutaneous T-cell lymphoma: facts and controversies","volume":"31","author":"Geskin","year":"2013","journal-title":"Clin Dermatol"},{"key":"24","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.3390\/toxins5081402","article-title":"Bacterial toxins fuel disease progression in cutaneous T-cell lymphoma","volume":"5","author":"Odum","year":"2013","journal-title":"Toxins"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-08-662353","article-title":"Staphylococcus aureus enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphoma","author":"Geisler","year":"2016","journal-title":"Blood"},{"key":"26","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrc1840","article-title":"Oncomirs - microRNAs with a role in cancer","volume":"6","author":"Slack","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"27","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.4161\/cc.24987","article-title":"STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma","volume":"12","author":"Geisler","year":"2013","journal-title":"Cell cycle"},{"key":"28","doi-asserted-by":"crossref","first-page":"957","DOI":"10.3109\/10428194.2013.815352","article-title":"Validation of a diagnostic microRNA classifier in cutaneous T-cell lymphomas","volume":"55","author":"Gniadecki","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"29","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1038\/cddis.2011.32","article-title":"MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in Sezary syndrome","volume":"2","author":"Ferracin","year":"2011","journal-title":"Cell Death Dis"},{"key":"30","doi-asserted-by":"crossref","first-page":"5891","DOI":"10.1182\/blood-2011-06-358382","article-title":"Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL)","volume":"118","author":"Sokilde","year":"2011","journal-title":"Blood"},{"key":"31","first-page":"7207","article-title":"MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma","volume":"34","author":"Krejsgaard","year":"2014","journal-title":"Anticancer Res"},{"key":"32","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.molonc.2011.02.003","article-title":"miRNA expression profiling of mycosis fungoides","volume":"5","author":"Lawrie","year":"2011","journal-title":"Mol Oncol"},{"key":"33","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/exd.12161","article-title":"miR- 155 is involved in tumor progression of mycosis fungoides","volume":"22","author":"Hodak","year":"2013","journal-title":"Exp dermatol"},{"key":"34","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/jid.2014.487","article-title":"MicroRNA expression profiling and DNA methylation signature for deregulated microRNA in cutaneous T-cell lymphoma","volume":"135","author":"Pujol","year":"2015","journal-title":"J Invest Dermatol"},{"key":"35","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1182\/blood-2009-12-256719","article-title":"MicroRNA expression in Sezary syndrome: identification, function, and diagnostic potential","volume":"116","author":"Pezzella","year":"2010","journal-title":"Blood"},{"key":"36","doi-asserted-by":"publisher","first-page":"20555","DOI":"10.18632\/oncotarget.4111","article-title":"Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma","volume":"6","author":"Sasseville","year":"2015","journal-title":"Oncotarget"},{"key":"37","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.1158\/0008-5472.CAN-13-3555","article-title":"A regulatory loop involving miR-22, Sp1, and c-Myc modulates CD147 expression in breast cancer invasion and metastasis","volume":"74","author":"Chen","year":"2014","journal-title":"Cancer Res"},{"key":"38","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.3892\/or.2013.2300","article-title":"miRNA-22 suppresses colon cancer cell migration and invasion by inhibiting the expression of T-cell lymphoma invasion and metastasis 1 and matrix metalloproteinases 2 and 9","volume":"29","author":"Xie","year":"2013","journal-title":"Oncol Rep"},{"key":"39","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nature10888","article-title":"The microcosmos of cancer","volume":"482","author":"Lowe","year":"2012","journal-title":"Nature"},{"key":"40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/imm.12367","article-title":"Immuno-miRs: critical regulators of T-cell development, function and ageing","volume":"144","author":"Kluiver","year":"2015","journal-title":"Immunology"},{"key":"41","doi-asserted-by":"crossref","first-page":"e76217","DOI":"10.1371\/journal.pone.0076217","article-title":"Dual role of miR-21 in CD4+ T-cells: activation-induced miR-21 supports survival of memory T-cells and regulates CCR7 expression in naive T-cells","volume":"8","author":"Kroesen","year":"2013","journal-title":"PloS one"},{"key":"42","doi-asserted-by":"crossref","first-page":"706","DOI":"10.4161\/rna.8.5.16154","article-title":"Regulation and function of miRNA-21 in health and disease","volume":"8","author":"Thum","year":"2011","journal-title":"RNA Biol"},{"key":"43","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1101\/gad.1444406","article-title":"Extensive post-transcriptional regulation of microRNAs and its implications for cancer","volume":"20","author":"Hammond","year":"2006","journal-title":"Genes Dev"},{"key":"44","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1053\/j.gastro.2007.05.022","article-title":"MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer","volume":"133","author":"Patel","year":"2007","journal-title":"Gastroenterology"},{"key":"45","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/cr.2008.24","article-title":"MicroRNA-21 targets tumor suppressor genes in invasion and metastasis","volume":"18","author":"Mo","year":"2008","journal-title":"Cell Res"},{"key":"46","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1182\/blood-2013-06-510578","article-title":"Comprehensive analysis of PTEN status in Sezary syndrome","volume":"122","author":"Caprini","year":"2013","journal-title":"Blood"},{"key":"47","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1373\/clinchem.2010.151845","article-title":"Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer","volume":"57","author":"Hoon","year":"2011","journal-title":"Clinical chemistry"},{"key":"48","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.molcel.2010.07.023","article-title":"STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer","volume":"39","author":"Struhl","year":"2010","journal-title":"Mol Cell"},{"key":"49","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.1073\/pnas.1101795108","article-title":"Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer","volume":"108","author":"Croce","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"50","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10585-010-9355-7","article-title":"High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients","volume":"28","author":"Nielsen","year":"2011","journal-title":"Clin Exp Metastasis"},{"key":"51","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1182\/blood-2007-03-081133","article-title":"Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer","volume":"110","author":"Stadler","year":"2007","journal-title":"Blood"},{"key":"52","doi-asserted-by":"crossref","first-page":"e85123","DOI":"10.1371\/journal.pone.0085123","article-title":"MiR-21 is under control of STAT5 but is dispensable for mammary development and lactation","volume":"9","author":"Hennighausen","year":"2014","journal-title":"PloS one"},{"key":"53","doi-asserted-by":"crossref","first-page":"8108","DOI":"10.1158\/0008-5472.CAN-10-2579","article-title":"IFN induces miR-21 through a signal transducer and activator of transcription 3-dependent pathway as a suppressive negative feedback on IFN-induced apoptosis","volume":"70","author":"Pfeffer","year":"2010","journal-title":"Cancer Res"},{"key":"54","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/CCO.0000000000000243","article-title":"Tumor microenvironment in mycosis fungoides and Sezary syndrome","volume":"28","author":"Querfeld","year":"2016","journal-title":"Curr Opin Oncol"},{"key":"55","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nri1901","article-title":"The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design","volume":"6","author":"Waldmann","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"56","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1038\/jid.2014.199","article-title":"Exploring the IL-21-STAT3 axis as therapeutic target for Sezary syndrome","volume":"134","author":"Vermeer","year":"2014","journal-title":"J Invest Dermatol"},{"key":"57","doi-asserted-by":"crossref","first-page":"253","DOI":"10.4049\/jimmunol.1101563","article-title":"BLIMP-1 and STAT3 counterregulate microRNA-21 during plasma cell differentiation","volume":"189","author":"Doody","year":"2012","journal-title":"J Immunol"},{"key":"58","doi-asserted-by":"crossref","first-page":"11977","DOI":"10.1073\/pnas.1100319108","article-title":"IL-2R common gamma-chain is epigenetically silenced by nucleophosphin-anaplastic lymphoma kinase (NPM-ALK) and acts as a tumor suppressor by targeting NPM-ALK","volume":"108","author":"Wasik","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"59","doi-asserted-by":"crossref","first-page":"e59563","DOI":"10.1371\/journal.pone.0059563","article-title":"CD24 induces expression of the oncomir miR-21 via Src, and CD24 and Src are both post-transcriptionally downregulated by the tumor suppressor miR-34a","volume":"8","author":"Allgayer","year":"2013","journal-title":"PloS one"},{"key":"60","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s12967-015-0570-5","article-title":"MiR-21: an environmental driver of malignant melanoma?","volume":"13","author":"Melnik","year":"2015","journal-title":"J Transl Med"},{"key":"61","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1242\/jcs.086710","article-title":"MicroRNA-21 is an important downstream component of BMP signalling in epidermal keratinocytes","volume":"124","author":"Botchkareva","year":"2011","journal-title":"Journal of cell science"},{"key":"62","doi-asserted-by":"crossref","first-page":"e610","DOI":"10.1371\/journal.pone.0000610","article-title":"MicroRNAs: novel regulators involved in the pathogenesis of psoriasis?","volume":"2","author":"Pivarcsi","year":"2007","journal-title":"PloS one"},{"key":"63","doi-asserted-by":"crossref","first-page":"29324","DOI":"10.1074\/jbc.M112.382135","article-title":"Induction of specific microRNAs inhibits cutaneous wound healing","volume":"287","author":"Tomic-Canic","year":"2012","journal-title":"J Biol Chem"},{"key":"64","doi-asserted-by":"publisher","first-page":"7262","DOI":"10.18632\/oncotarget.3225","article-title":"Stratifying risk of recurrence in stage II colorectal cancer using deregulated stromal and epithelial microRNAs","volume":"6","author":"Mirnezami","year":"2015","journal-title":"Oncotarget"},{"key":"65","doi-asserted-by":"publisher","first-page":"10521","DOI":"10.18632\/oncotarget.3294","article-title":"Integrated genomic analysis identifies subclasses and prognosis signatures of kidney cancer","volume":"6","author":"Krek","year":"2015","journal-title":"Oncotarget"},{"key":"66","doi-asserted-by":"publisher","first-page":"15035","DOI":"10.18632\/oncotarget.3729","article-title":"MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K\/AKT pathway in diffuse large B-cell lymphoma","volume":"6","author":"Jeon","year":"2015","journal-title":"Oncotarget"},{"key":"67","doi-asserted-by":"publisher","first-page":"32545","DOI":"10.18632\/oncotarget.5324","article-title":"MicroRNAs as prognostic molecular signatures in renal cell carcinoma: a systematic review and meta-analysis","volume":"6","author":"Zhang","year":"2015","journal-title":"Oncotarget"},{"key":"68","doi-asserted-by":"publisher","first-page":"12672","DOI":"10.18632\/oncotarget.7208","article-title":"miR-21 expression and clinical outcome in locally advanced pancreatic cancer: exploratory analysis of the pancreatic cancer Erbitux, radiotherapy and UFT (PERU) trial","volume":"7","author":"Guzzardo","year":"2016","journal-title":"Oncotarget"},{"key":"69","doi-asserted-by":"publisher","first-page":"9484","DOI":"10.18632\/oncotarget.2419","article-title":"What makes a blood cell based miRNA expression pattern disease specific?--a miRNome analysis of blood cell subsets in lung cancer patients and healthy controls","volume":"5","author":"Meese","year":"2014","journal-title":"Oncotarget"},{"key":"70","doi-asserted-by":"publisher","first-page":"26971","DOI":"10.18632\/oncotarget.4699","article-title":"Exosomal levels of miRNA-21 from cerebrospinal fluids associated with poor prognosis and tumor recurrence of glioma patients","volume":"6","author":"Cheng","year":"2015","journal-title":"Oncotarget"},{"key":"71","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/QAI.0000000000000146","article-title":"Serum microRNAs in HIV-infected individuals as pre-diagnosis biomarkers for AIDS-NHL","volume":"66","author":"Martinez-Maza","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"key":"72","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","article-title":"Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)","volume":"110","author":"Ranki","year":"2007","journal-title":"Blood"},{"key":"73","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/apm.12162","article-title":"Expression of miR-155 and miR-126in cutaneous T-cell lymphoma","volume":"121","author":"Ralfkiaer","year":"2013","journal-title":"APMIS"},{"key":"74","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/0165-4608(95)00118-2","article-title":"Common clonal chromosome aberrations in cytokine-dependent continuous human T-lymphocyte cell lines","volume":"85","author":"Thestrup-Pedersen","year":"1995","journal-title":"Cancer Genet Cytogenet"},{"key":"75","doi-asserted-by":"crossref","first-page":"6094","DOI":"10.1128\/MCB.24.13.6094-6103.2004","article-title":"SOCS5 is expressed in primary B and T lymphoid cells but is dispensable for lymphocyte production and function","volume":"24","author":"Alexander","year":"2004","journal-title":"Mol Cell Biol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.10160","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T12:47:03Z","timestamp":1596718023000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.10160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,18]]},"references-count":75,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2016,7,19]]}},"alternative-id":["10160","27329723"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.10160","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,18]]}}}